Advances in pharmacotherapy of asthma.
Haahtela
T
T
Department of Allergology, Helsinki University Hospital, Huch, Finland.
D000281:Administration, Intranasal; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005544:Forecasting; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D017835:Nedocromil / Q000008:administration & dosage / Q000627:therapeutic use; D018343:Receptors, Adrenergic, beta-2 / Q000187:drug effects; D012189:Retrospective Studies; D013806:Theophylline / Q000008:administration & dosage / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D020024:Leukotriene Antagonists; D018343:Receptors, Adrenergic, beta-2; D017835:Nedocromil; D013806:Theophylline; D004205:Cromolyn Sodium